Cytosorbents (CTSO) Net Margin Growth (1y) (2012 - 2026)
Cytosorbents (CTSO) Net Margin Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -860.00 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 469.00 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 94.00 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 92.00 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -777.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 350.00 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 85.00 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -81.00 |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 67.00 |
| 10 | Cytosorbents | 19.47 Mn | 15.06 Mn | 7.05 Mn | -6,610.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6,610.00 |
| Mar 31, 2026 | -4,092.00 |
| Dec 31, 2025 | 2,316.00 |
| Sep 30, 2025 | -128.00 |
| Jun 30, 2025 | 6,881.00 |
| Mar 31, 2025 | 5,378.00 |
| Dec 31, 2024 | -1,538.00 |
| Sep 30, 2024 | 7,221.00 |
| Jun 30, 2024 | 1,675.00 |
| Mar 31, 2024 | 680.00 |
| Dec 31, 2023 | -5,916.00 |
| Sep 30, 2023 | 4,607.00 |
| Jun 30, 2023 | 6,274.00 |
| Mar 31, 2023 | 2,564.00 |
| Dec 31, 2022 | 7,816.00 |
| Sep 30, 2022 | -8,478.00 |
| Jun 30, 2022 | -8,916.00 |
| Mar 31, 2022 | -6,384.00 |
| Dec 31, 2021 | -8,065.00 |
| Sep 30, 2021 | -5,767.00 |